Page last updated: 2024-12-08

gentianine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gentianine: from Gentiana macrophylla [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
GentianagenusA plant genus of the family Gentianaceae whose members contain SECOIRIDOIDS and have been used in TRADITIONAL MEDICINE for suppressing INFLAMMATION.[MeSH]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]
Gentiana macrophyllaspecies[no description available]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID354616
CHEMBL ID4753058
CHEBI ID28981
SCHEMBL ID2216852
MeSH IDM0167859

Synonyms (40)

Synonym
NSC606848 ,
from schultesia guianensis malme (mata-zombando)
gencianina
nsc-606848
1h-pyrano(3,4-c)pyridin-1-one, 5-ethenyl-3,4-dihydro-
nicotinic acid, 4-(2-hydroxyethyl)-5-vinyl-, gamma-lactone
5-ethenyl-3,4-dihydro-1h-pyrano(3,4-c)pyridin-1-one
1h-pyrano(3,4-c)pyridin-1-one, 3,4-dihydro-5-vinyl-
brn 0137011
gentianine
C06525 ,
439-89-4
CHEBI:28981 ,
4-(2-hydroxyethyl)-5-vinylnicotinic acid gamma-lactone
5-ethenyl-3,4-dihydro-1h-pyrano[3,4-c]pyridin-1-one
5-ethenyl-3,4-dihydropyrano[3,4-c]pyridin-1-one
AKOS005266580
c2pd310uxb ,
unii-c2pd310uxb
4-27-00-02817 (beilstein handbook reference)
erythricine
SCHEMBL2216852
gentiannine
Q-100479
1h-pyrano[3,4-c]pyridin-1-one, 5-ethenyl-3,4-dihydro-
gentianine [mi]
nicotinic acid, 4-(2-hydroxyethyl)-5-vinyl-, .delta.-lactone
5-vinyl-3,4-dihydropyrano(3,4-c)pyridin-1-one
5-ethenyl-1h,3h,4h-pyrano[3,4-c]pyridin-1-one
HY-N6039
5-vinyl-3,4-dihydro-1h-pyrano[3,4-c]pyridin-1-one
VS-13618
Q27104004
STL559047
BBL036668
DTXSID00963141
CS-0032220
CHEMBL4753058
nicotinic acid, 4-(2-hydroxyethyl)-5-vinyl-, delta-lactone
PD127696

Research Excerpts

Overview

Gentianine is an active metabolite of swertiamarin. It possesses a pharmacophoric moiety.

ExcerptReferenceRelevance
"Gentianine is an active metabolite of swertiamarin that possesses a pharmacophoric moiety."( Anti-diabetic activity of swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR-γ gene expression in 3T3-L1 cells.
Cheema, SK; Goyal, RK; Vaidya, H, 2013
)
1.34

Treatment

ExcerptReferenceRelevance
"Gentianine co-treatment with TLR4 inhibitor, further decreased TLR4, MyD88 and NF-κB expression, NO production, as well as the inflammatory cytokines."( Machine learning enables discovery of Gentianine targeting TLR4/NF-κB pathway to repair ischemic stroke injury.
Chen, J; Gao, C; Jia, C; Li, Z; Liu, Y; Wang, N; Wu, C; Wu, M; Zhang, Q; Zhao, X; Zheng, T, 2021
)
1.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
pyridine alkaloid
pyranopyridine
lactoneAny cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1682131Toxicity in ip dosed albino rat2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682135Antiaggressive activity in mouse assessed as reduction in foot shock induced fighting behavior2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682137Antipsychotic activity in albino mouse assessed as potentiation of hexobarbital-induced sleeping time2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682134Potentiation of morphine-induced analgesia in rat relative to control2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682132Protection against pentylenetetrazol-induced convulsion in rat at 50 to 100 mg/kg, ip relative to control2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682133Potentiation of diphenylhydantoin-induced anticonvulsant activity in rat relative to control2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682136Antipsychotic activity in trained mouse assessed as reduction in ability of mouse to remain on rotating rod2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682138Antipsychotic activity in mouse assessed as reduction in amphetamine-induced toxicity2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's5 (45.45)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.64 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]